Silexion Therapeutics's three largest insider shareholders as of September 29, 2026 are Ilan Hadar (Chairman And Ceo, 16.55K shares), Hadar Mirit Horenshtein (Cfo And Secretary, 12.52K shares), Mitchell Shirvan (Cso And Cdo, 8.79K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Ilan Hadar | Chairman And Ceo | 16,547 | 0 | 16,547 | 43.6% | 08 Jun, 2026 |
| 2 | Hadar Mirit Horenshtein | Cfo And Secretary | 12,515 | 0 | 12,515 | 33.0% | 08 Jun, 2026 |
| 3 | Mitchell Shirvan | Cso And Cdo | 8,789 | 0 | 8,789 | 23.2% | 08 Jun, 2026 |
| 4 | Shlomo Noy | Director | 0 | 19 | 19 | 0.0% | 25 Feb, 2026 |
| 5 | Avner Lushi | Director | 0 | 19 | 19 | 0.0% | 23 Feb, 2026 |
| 6 | Ruth Alon | Director | 8 | 0 | 8 | 0.0% | 23 Feb, 2026 |
| 7 | Dror Yosef Abramov | Director | 8 | 0 | 8 | 0.0% | 23 Feb, 2026 |
| 8 | Amnon Peled | Director | 6 | 0 | 6 | 0.0% | 23 Feb, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 04 Jun, 2026 | Mitchell Shirvan | Cso And Cdo | Acquired A | 6,000 | $0.00 | $0 | 8,789 | Direct |
| 04 Jun, 2026 | Hadar Mirit Horenshtein | Cfo And Secretary | Acquired A | 7,500 | $0.00 | $0 | 12,515 | Direct |
| 04 Jun, 2026 | Ilan Hadar | Chairman And Ceo | Acquired A | 10,000 | $0.00 | $0 | 16,547 | Direct |
| 26 Mar, 2026 | Mitchell Shirvan | Cso And Cdo | Disposed S | 22,818 | $1,835.93 | $41.89Mn | 21 | Direct |
| 20 Feb, 2026 | Shlomo Noy | Director | Acquired A | 9,091 | $0.00 | $0 | 19 | Indirect |
| 20 Feb, 2026 | Shlomo Noy | Director | Acquired A | 10,685 | $0.00 | $0 | 8 | Indirect |
| 20 Feb, 2026 | Amnon Peled | Director | Acquired A | 7,576 | $0.00 | $0 | 6 | Direct |
| 20 Feb, 2026 | Ilan Hadar | Chairman And Ceo | Acquired A | 64,350 | $0.00 | $0 | 49 | Direct |
| 20 Feb, 2026 | Mitchell Shirvan | Cso And Cdo | Acquired A | 49,726 | $0.00 | $0 | 38 | Direct |
| 20 Feb, 2026 | Ruth Alon | Director | Acquired A | 9,091 | $0.00 | $0 | 8 | Direct |
| 20 Feb, 2026 | Hadar Mirit Horenshtein | Cfo And Secretary | Acquired A | 49,726 | $0.00 | $0 | 37 | Direct |
| 20 Feb, 2026 | Avner Lushi | Director | Acquired A | 9,091 | $0.00 | $0 | 19 | Indirect |
| 20 Feb, 2026 | Dror Yosef Abramov | Director | Acquired A | 9,091 | $0.00 | $0 | 8 | Direct |
| 20 Feb, 2026 | Dror Yosef Abramov | Director | Acquired A | 10,685 | $0.00 | $0 | 8 | Direct |
| 20 Feb, 2026 | Ruth Alon | Director | Acquired A | 10,685 | $0.00 | $0 | 8 | Direct |
| 20 Feb, 2026 | Amnon Peled | Director | Acquired A | 8,904 | $0.00 | $0 | 7 | Direct |
| 20 Feb, 2026 | Avner Lushi | Director | Acquired A | 10,685 | $0.00 | $0 | 8 | Indirect |